The Impact of Comorbidities on Outcomes in the Multiple Sclerosis Population: a Rapid Review Protocol

Hanna A. Frank,Melissa Chao,Helen Tremlett,Ruth Ann Marrie,Lisa M. Lix,Kyla A. McKay,Fardowsa Yusuf,Feng Zhu,Mohammad Ehsanul Karim
DOI: https://doi.org/10.21203/rs.3.pex-2438/v1
IF: 4.808
2024-01-01
Multiple Sclerosis and Related Disorders
Abstract:Abstract Introduction: People with multiple sclerosis (MS) experience higher comorbidity burden than the non-MS population. Research has shown that having comorbidities alongside MS can lead to worse MS outcomes, including faster rates of disability progression, delays in initiating disease-modifying treatments, and earlier death. A comprehensive overview of which comorbidities affect these outcomes has not yet been published. This review aims to summarize what is currently known about these relationships to inform the development of a comorbidity index specific to people with MS. Methods and analysis: A rapid review structure will be implemented that is in line with the current recommendations by the Cochrane Rapid Review Methods Group. Two databases will be searched (MEDLINE and EMBASE) and a grey literature search will be included. The Newcastle-Ottawa scale will be used for a risk of bias assessment. Results will be displayed visually in tables and graphs, as well as through a narrative synthesis. Ethics and dissemination: Ethics approval is not required for this review. The rapid review will be submitted for publication in peer-reviewed journals. The results will also be disseminated through conferences and seminars. PROSPERO registration number: CRD42023475565
What problem does this paper attempt to address?